The need to manage the risk of thromboembolism in COVID-19 patients



Khan, Inayat Hussain, Savarimuthu, Sugeevan, Leung, Marco Shiu Tsun and Harky, Amer ORCID: 0000-0001-5507-5841
(2020) The need to manage the risk of thromboembolism in COVID-19 patients. JOURNAL OF VASCULAR SURGERY, 72 (3). pp. 799-804.

Access the full-text of this item by clicking on the Open Access link.

Abstract

COVID-19 first appeared in Wuhan, Hubei Province, China, in December 2019. Thought to be of zoonotic origin, it has been named SARS-CoV-2 (COVID-19) and has spread rapidly. As of April 20, 2020, there have been >2.4 million cases recorded worldwide. The inflammatory process, cytokine storm, and lung injury that are associated with COVID-19 can put patients at an increased risk of thrombosis. The total incidence of thrombotic events in COVID-19 patients is currently uncertain. Those with more severe disease and with other risk factors, including increasing age, male sex, obesity, cancer, comorbidities, and intensive care unit admission, are at higher risk of these events. However, there is little international guidance on managing these risks in COVID-19 patients. In this paper, we explore the current evidence and theories surrounding thrombosis in these unique patients and reflect on experience from our center.

Item Type: Article
Uncontrolled Keywords: COVID-19, Thrombosis, Venous thromboembolism, D-dimer, Anticoagulation
Depositing User: Symplectic Admin
Date Deposited: 26 May 2020 08:54
Last Modified: 18 Jan 2023 23:51
DOI: 10.1016/j.jvs.2020.05.015
Open Access URL: https://www.jvascsurg.org/article/S0741-5214(20)31...
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3088478